Biosimilars to transform the competition

At Medical, Marketing & Media, they look at how the new approval pathway for biologics will not only increase the marketing for the biosimilars but the biologics as well. Follow-on Biologics will change the shape of the market, as they will be more than just a generic. While biologics will have market exclusivity for 12 years, once a follow-on biologic is on the market, prices for these are only expected to be 20-30% lower.

Do you expect the marketing for biologics to change once they face competition from biosimilars? Read more about this topic at MM&M.

Share this article with your social network, just click below to share now!

Share |